Daejeon, Taejon-jikhalsi, South Korea In 1997 was created GeneChem Inc., which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Daejeon. The fund was located in Asia if to be more exact in South Korea.
The fund was created by Jinsuk Woo.
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2011. This GeneChem Inc. works on 38 percentage points more the average amount of lead investments comparing to the other organizations.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight BioVex, Cyclacel Pharmaceuticals. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom.
The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the GeneChem Inc., startups are often financed by Scottish Equity Partners, West Deutsche Landesbank Girozentrale, Technomark Medical Ventures. The meaningful sponsors for the fund in investment in the same round are Scottish Equity Partners, Temasek Holdings, Avalon Ventures. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.
Related Funds
| Fund Name | Location |
| Aon plc | England, London, United Kingdom |
| Apex Fund Services | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Beijing Ant Cell Tour International Travel Service | Beijing, Beijing, China |
| Chicago Venture Summit | Chicago, Illinois, United States |
| Commonwealth Research Commercialization Fund | - |
| CS Capital | China, Shanghai |
| European Commission | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| FIWARE | Berlin, Berlin, Germany |
| InterGen | Burlington, Massachusetts, United States |
| Lanqi Investment | - |
| Long March Investment Fund | - |
| Ospre Point Capital | - |
| Quarry | California, San Francisco, United States |
| Shift. | Seoul, Seoul-t'ukpyolsi, South Korea |
| The Batchery Angels | - |
| TiE LaunchPad | California, Sunnyvale, United States |
| TNP | Japan, Kanagawa Prefecture, Yokohama |
| TSK | Asturias, Gijón, Spain |
| Westlake Ventures | California, Redwood City, United States |
| Zhuhai Zhongle | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |
